The Albanese Government has released its 2023-24 Mid-Year Economic Fiscal Outlook, which includes $3.5 billion since the May Budget for new medicines on the PBS, but also an expected decline in spending on the program that must be qualified because the estimate does not include the impact of future new listings.
Update reveals significant spending on new listings since the May Budget
December 13, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Patients move to reclaim access agenda ahead of sector negotiations
July 15, 2026 - - Latest News -
Minister recommits to keeping MS medicines on the PBS while awaiting formal advice
July 15, 2026 - - Latest News -
Budget outlook now hangs on disability savings, but what about pharmaceuticals
July 15, 2026 - - Latest News -
Australian partnership advances gene therapy for Retinitis Pigmentosa
July 15, 2026 - - Latest News -
An opportunity to become a global destination for paediatric oncology trials
July 15, 2026 - - Latest News -
Widening inequality threatens outcomes for Australians with neuroendocrine cancer
July 14, 2026 - - Latest News -
Can GLP-1s be more transformative than AI - one person believes they already are
July 14, 2026 - - Latest News

